Gene therapy, early promises, subsequent problems, and recent breakthroughs
View/ Open
Date
2013Author
Soofiyani, SR
Baradaran, B
Lotfipour, F
Kazemi, T
Mohammadnejad, L
Metadata
Show full item recordAbstract
Gene therapy is one of the most attractive fields in medicine. The concept of gene delivery to tissues for clinical applications has been discussed around half a century, but scientist's ability to manipulate genetic material via recombinant DNA technology made this purpose to reality. Various approaches, such as viral and non-viral vectors and physical methods, have been developed to make gene delivery safer and more efficient. While gene therapy initially conceived as a way to treat life-threatening disorders (inborn errors, cancers) refractory to conventional treatment, to date gene therapy is considered for many non-life-threatening conditions including those adversely influence on a patient's quality of life. Gene therapy has made significant progress, including tangible success, although much slower than was initially predicted. Although, gene therapies still at a fairly primitive stage, it is firmly science based. There is justifiable hope that with enhanced pathobiological understanding and biotechnological improvements, gene therapy will be a standard part of clinical practice within 20 years. é 2013 by Tabriz University of Medical Sciences.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Gelatin-based delivery systems for cancer gene therapy cancer gene therapy
Nezhadi, SH; Choong, PFM; Lotfipour, F; Dass, CR (2009)Gelatin is a natural, biocompatible, nontoxic, edible, and inexpensive macromolecule. These properties result in its wide application in pharmaceutical, medical, and cosmetic products. Recently, it has been used for the ... -
Epigenetic Modifications and Therapy in Multiple Sclerosis.
Aslani, S; Jafari, N; Javan, MR; Karami, J; Ahmadi, M; Jafarnejad, M (2017)Breakthroughs in genetic studies, like whole human genome sequencing and genome-wide association studies (GWAS), have richened our knowledge of etiopathology of autoimmune diseases (AID) through discovery of genetic patterns. ... -
Nanoparticle-mediated interleukin-12 cancer gene therapy.
Hallaj-Nezhadi, S; Lotfipour, F; Dass, C (2010)Interleukin-12 (Il-12) is a heterodimeric cytokine which has been proven to possess antitumor effects in various animal models via stimulating the immune system. However, the main problem associated with Il-12 protein ...